3/12
08:05 am
imcr
Immunocore Holdings plc (NASDAQ: IMCR) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $71.00 price target on the stock.
Low
Report
Immunocore Holdings plc (NASDAQ: IMCR) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $71.00 price target on the stock.
3/12
08:05 am
imcr
Immunocore Holdings plc (NASDAQ: IMCR) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $100.00 price target on the stock.
Low
Report
Immunocore Holdings plc (NASDAQ: IMCR) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $100.00 price target on the stock.
3/10
03:00 pm
imcr
Immunocore presents initial multiple ascending dose data for HIV functional cure candidate in an oral presentation at CROI 2025
Low
Report
Immunocore presents initial multiple ascending dose data for HIV functional cure candidate in an oral presentation at CROI 2025
3/7
12:54 pm
imcr
Immunocore Holdings plc (NASDAQ: IMCR) had its "equal weight" rating re-affirmed by analysts at Morgan Stanley. They now have a $35.00 price target on the stock.
Low
Report
Immunocore Holdings plc (NASDAQ: IMCR) had its "equal weight" rating re-affirmed by analysts at Morgan Stanley. They now have a $35.00 price target on the stock.
3/6
02:26 pm
imcr
TCR Therapy Clinical Trial Pipeline Accelerates as 80+ Pharma Companies Rigorously Developing Drugs for the Market Entry | DelveInsight [Yahoo! Finance]
Low
Report
TCR Therapy Clinical Trial Pipeline Accelerates as 80+ Pharma Companies Rigorously Developing Drugs for the Market Entry | DelveInsight [Yahoo! Finance]
3/3
07:00 am
imcr
Immunocore to present at upcoming investor conferences
Low
Report
Immunocore to present at upcoming investor conferences
3/1
07:07 pm
imcr
The Immunocore Holdings plc (NASDAQ:IMCR) Full-Year Results Are Out And Analysts Have Published New Forecasts [Yahoo! Finance]
Low
Report
The Immunocore Holdings plc (NASDAQ:IMCR) Full-Year Results Are Out And Analysts Have Published New Forecasts [Yahoo! Finance]
2/28
09:48 am
imcr
Immunocore Holdings plc (NASDAQ: IMCR) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $100.00 price target on the stock.
Low
Report
Immunocore Holdings plc (NASDAQ: IMCR) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $100.00 price target on the stock.
2/27
08:08 am
imcr
Immunocore Holdings plc (NASDAQ: IMCR) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $71.00 price target on the stock.
Medium
Report
Immunocore Holdings plc (NASDAQ: IMCR) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $71.00 price target on the stock.
2/26
07:00 am
imcr
Immunocore reports fourth quarter and full year 2024 financial results and provides a business update
Medium
Report
Immunocore reports fourth quarter and full year 2024 financial results and provides a business update
2/25
10:52 am
imcr
Earnings To Watch: Immunocore Holdings PLC (IMCR) Reports Q4 2024 Result [Yahoo! Finance]
Medium
Report
Earnings To Watch: Immunocore Holdings PLC (IMCR) Reports Q4 2024 Result [Yahoo! Finance]
2/20
07:17 pm
imcr
Lilly's former M&A chief scours the landscape for potential deals as Immunocore's new CFO [Yahoo! Finance]
Low
Report
Lilly's former M&A chief scours the landscape for potential deals as Immunocore's new CFO [Yahoo! Finance]
2/19
07:07 pm
imcr
Immunocore to report fourth quarter and full year 2024 financial results and host call on February 26, 2025 [Yahoo! Finance]
Low
Report
Immunocore to report fourth quarter and full year 2024 financial results and host call on February 26, 2025 [Yahoo! Finance]
2/19
07:00 am
imcr
Immunocore to report fourth quarter and full year 2024 financial results and host call on February 26, 2025
Low
Report
Immunocore to report fourth quarter and full year 2024 financial results and host call on February 26, 2025
1/27
08:02 am
imcr
Immunocore Holdings plc (NASDAQ: IMCR) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $100.00 price target on the stock.
Medium
Report
Immunocore Holdings plc (NASDAQ: IMCR) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $100.00 price target on the stock.
1/10
12:47 pm
imcr
Immunocore Holdings plc (NASDAQ: IMCR) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $71.00 price target on the stock.
Low
Report
Immunocore Holdings plc (NASDAQ: IMCR) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $71.00 price target on the stock.
1/10
08:05 am
imcr
Immunocore reports cash, equivalents of $820M as of December 31 [Seeking Alpha]
Low
Report
Immunocore reports cash, equivalents of $820M as of December 31 [Seeking Alpha]
1/10
07:00 am
imcr
Immunocore announces strategic priorities at 43rd Annual J.P. Morgan Healthcare Conference
Low
Report
Immunocore announces strategic priorities at 43rd Annual J.P. Morgan Healthcare Conference
1/6
07:00 am
imcr
Immunocore to present at the 43rd Annual J.P. Morgan Healthcare Conference
Low
Report
Immunocore to present at the 43rd Annual J.P. Morgan Healthcare Conference
1/2
07:36 am
imcr
Immunocore appoints Travis Coy, previously a Non-Executive Director, as its EVP, Chief Financial Officer and Head of Corporate Development [Yahoo! Finance]
Low
Report
Immunocore appoints Travis Coy, previously a Non-Executive Director, as its EVP, Chief Financial Officer and Head of Corporate Development [Yahoo! Finance]
1/2
07:00 am
imcr
Immunocore appoints Travis Coy, previously a Non-Executive Director, as its EVP, Chief Financial Officer and Head of Corporate Development
Low
Report
Immunocore appoints Travis Coy, previously a Non-Executive Director, as its EVP, Chief Financial Officer and Head of Corporate Development
12/26
03:14 pm
imcr
3 Beaten-Down Biotech Stocks to Buy for a Turnaround in 2025 [Yahoo! Finance]
Low
Report
3 Beaten-Down Biotech Stocks to Buy for a Turnaround in 2025 [Yahoo! Finance]
12/24
12:25 pm
imcr
BMY Gets EC Nod for Opdivo Plus Yervoy in First-Line Colorectal Cancer [Yahoo! Finance]
Low
Report
BMY Gets EC Nod for Opdivo Plus Yervoy in First-Line Colorectal Cancer [Yahoo! Finance]
12/23
09:17 am
imcr
Buy 5 Genomics & Synthetic Biology Stocks Likely to Soar in Short Term [Yahoo! Finance]
Low
Report
Buy 5 Genomics & Synthetic Biology Stocks Likely to Soar in Short Term [Yahoo! Finance]
12/23
07:17 am
imcr
Immunocore announces first patient dosed in the Phase 1 trial of IMC-P115C, a half-life extended (HLE) ImmTAC candidate in patients with tumors that express PRAME [Yahoo! Finance]
Medium
Report
Immunocore announces first patient dosed in the Phase 1 trial of IMC-P115C, a half-life extended (HLE) ImmTAC candidate in patients with tumors that express PRAME [Yahoo! Finance]